Charles Sternberg is a driven writer and editor with a well developed passion for creativity and innovation seeking to ...

Overcoming distribution hurdles to meet demand, cold chain solutions and strategies, and streamlining the supply chain to mitigate rising costs. Unique capabilities needed to overcome obstacles for ...

Risk assessment approaches, employing appropriate control strategies, and robust analytical methods can ensure high-quality and safe medicines. Tips to avoid IP contamination in manufacturing ...

Prasinezumab continues to be well tolerated and no new safety signals were observed.

Will support clinical development of Nirsum’s lead development candidate, NRS-033.

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of ...

The acquisition is expected to be completed in the coming days.

A Phase 2 study showed encouraging results with Trodelvy as a second-line treatment for extensive-stage small cell lung ...

In anticipation of restarting clinical studies of various DPX formulations and initiating new preclinical studies, BioVaxys ...

With a total area exceeding 16,000 square meters, the new facility houses the company's production, quality, data, and ...

Dr. Marc Damelin possesses extensive industry experience in oncology drug discovery and development across a variety of mechanisms of action. Adds Nimble's lead asset and a pipeline of other novel ...

Partnership leverages PHICS technology to bring together a kinase and target of interest to modulate protein function.